56 research outputs found
Examining Health Outcomes in Juvenile Idiopathic Arthritis:A Genetic Epidemiology Study
OBJECTIVE: Juvenile idiopathic arthritis (JIA) is the most common pediatric rheumatic disease; however, little is known about its wider health impacts. This study explores health outcomes associated with JIA genetic liability. METHODS: We used publicly available genetic data sets to interrogate the genetic correlation between JIA and 832 other healthârelated traits using linkage disequilibrium score regression. Twoâsample Mendelian randomization (2SMR) was used to examine four genetic correlates for evidence of causality. RESULTS: We found robust evidence (adjusted P [P (adj)]â<â0.05) of genetic correlation between JIA and rheumatoid arthritis (genetic correlation [r (g)]Â =Â 0.63, P (adj)Â =Â 0.029), hypothyroidism/myxedema (r (g)Â =Â 0.61, P (adj)Â =Â 0.041), celiac disease (CD) (r (g)Â =Â 0.58, P (adj)Â =Â 0.032), systemic lupus erythematosus (r (g)Â =Â 0.40, P (adj)Â =Â 0.032), coronary artery disease (CAD) (r (g)Â =Â 0.42, P (adj)Â =Â 0.006), number of noncancer illnesses (r (g)Â =Â 0.42, P (adj)Â =Â 0.016), paternal health (r (g)Â =Â 0.57, P (adj)Â =Â 0.032), and strenuous sports (r (g)Â =Â â0.52, P (adj)Â =Â 0.032). 2SMR analyses found robust evidence that genetic liability to JIA was causally associated with the number of noncancer illnesses reported by UK Biobank (UKBB) participants (increase of 0.03 noncancer illnesses per doubling odds of JIA, 95% confidence interval 0.01â0.05). CONCLUSION: This study illustrates genetic sharing between JIA and a diversity of health outcomes. The causal association between genetic liability to JIA and noncancer illnesses suggests a need for broader health assessments of patients with JIA to reduce their potential comorbid burden. The strength of genetic correlation with hypothyroidism and CD implies that patients with JIA may benefit from CD and thyroid function screening. Strong positive genetic correlation between JIA and CAD supports the need for cardiovascular risk assessment and risk factor modification
Two-year outcomes following a randomised platelet transfusion trial in preterm infants
Objective: Assess mortality and neurodevelopmental outcomes at 2 years of corrected age in children who participated in the PlaNeT-2/MATISSE (Platelets for Neonatal Transfusion - 2/Management of Thrombocytopenia in Special Subgroup) study, which reported that a higher platelet transfusion threshold was associated with significantly increased mortality or major bleeding compared to a lower one. Design: Randomised clinical trial, enrolling from June 2011 to August 2017. Follow-up was complete by January 2020. Caregivers were not blinded; however, outcome assessors were blinded to treatment group. Setting: 43 level II/III/IV neonatal intensive care units (NICUs) across UK, Netherlands and Ireland. Patients: 660 infants born at less than 34 weeks' gestation with platelet counts less than 50Ă109/L. Interventions: Infants were randomised to undergo a platelet transfusion at platelet count thresholds of 50Ă109/L (higher threshold group) or 25Ă109/L (lower threshold group). Main outcomes measures: Our prespecified long-term follow-up outcome was a composite of death or neurodevelopmental impairment (developmental delay, cerebral palsy, seizure disorder, profound hearing or vision loss) at 2 years of corrected age. Results: Follow-up data were available for 601 of 653 (92%) eligible participants. Of the 296 infants assigned to the higher threshold group, 147 (50%) died or survived with neurodevelopmental impairment, as compared with 120 (39%) of 305 infants assigned to the lower threshold group (OR 1.54, 95% CI 1.09 to 2.17, p=0.017). Conclusions: Infants randomised to a higher platelet transfusion threshold of 50Ă109/L compared with 25Ă109/L had a higher rate of death or significant neurodevelopmental impairment at a corrected age of 2 years. This further supports evidence of harm caused by high prophylactic platelet transfusion thresholds in preterm infants. Trial registration number: ISRCTN87736839
P2X4 receptor function in the nervous system and current breakthroughs in pharmacology
ATP is a well-known extracellular signalling molecule and neurotransmitter known to activate purinergic P2X receptors. Information has been elucidated about the structure and gating of P2X channels following the determination of the crystal structure of P2X4 (zebrafish), however there is still much to discover regarding the role of this receptor in the central nervous system (CNS). In this review we provide an overview of what is known about P2X4 expression in the CNS and discuss evidence for pathophysiological roles in neuroinflammation and neuropathic pain. Recent advances in the development of pharmacological tools including selective antagonists (5-BDBD, PSB-12062, BX430) and positive modulators (ivermectin, avermectins, divalent cations) of P2X4 will be discussed
Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies.
Published versio
Barbarians at the British Museum: Anglo-Saxon Art, Race and Religion
A critical historiographical overview of art historical approaches to early medieval material culture, with a focus on the British Museum collections and their connections to religion
A New Natural Defense Against Airborne Pathogens
We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, completely block airborne transmission of disease. In a study of 10 human volunteers (5 less than 65Â years and 5 older than 65Â years), we show that delivery of a nasal saline comprising calcium and sodium salts quickly (within 15Â min) and durably (up to at least 6Â h) diminishes exhaled particles from the human airways. Being predominantly smaller than 1Â ÎŒm, these particles are below the size effectively filtered by conventional masks. The suppression of exhaled droplets by the nasal delivery of calcium-rich saline with aerosol droplet size of around 10Â ÎŒm suggests the upper airways as a primary source of bioaerosol generation. The suppression effect is especially pronounced (99%) among those who exhale large numbers of particles. In our study, we found this high-particle exhalation group to correlate with advanced age. We argue for a new hygienic practice of nasal cleansing by a calcium-rich saline aerosol, to complement the washing of hands with ordinary soap, use of a face mask, and social distancing
- âŠ